Stephen Willey
Stock Analyst at Stifel
(3.20)
# 1,230
Out of 4,412 analysts
72
Total ratings
37.33%
Success rate
4.09%
Average return
Main Sectors:
Top Industries:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEIP MEI Pharma | Maintains: Hold | $7 | $3.05 | +129.51% | 5 | Apr 12, 2024 | |
| CUE Cue Biopharma | Maintains: Buy | $8 | $1.37 | +486.08% | 5 | Apr 9, 2024 | |
| VOR Vor Biopharma | Maintains: Buy | $15 → $12 | $1.69 | +610.06% | 4 | Mar 21, 2024 | |
| INCY Incyte | Reiterates: Hold | $68 | $51.68 | +31.58% | 4 | Mar 12, 2024 | |
| MGNX MacroGenics | Maintains: Buy | $17 → $29 | $14.56 | +99.18% | 1 | Mar 8, 2024 | |
| ABCL AbCellera Biologics | Maintains: Buy | $21 → $17 | $3.76 | +352.13% | 1 | Feb 21, 2024 | |
| EXEL Exelixis | Maintains: Hold | $23 → $25 | $23.70 | +5.49% | 8 | Feb 2, 2024 | |
| CGEN Compugen | Maintains: Buy | $3 → $4 | $1.92 | +108.33% | 1 | Dec 19, 2023 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $53 → $62 | $40.50 | +53.09% | 4 | Dec 18, 2023 | |
| IGMS IGM Biosciences | Maintains: Buy | $26 → $25 | $9.40 | +165.96% | 2 | Nov 14, 2023 | |
| HLVX HilleVax | Maintains: Buy | $35 → $30 | $12.79 | +134.56% | 2 | Nov 10, 2023 | |
| BCEL Atreca | Downgrades: Hold | $4 → $1 | $0.08 | +1,150.00% | 3 | Aug 11, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $4 → $5 | $1.17 | +329.18% | 1 | May 17, 2023 | |
| NKTX Nkarta | Maintains: Buy | $21 → $18 | $6.87 | +162.01% | 2 | May 12, 2023 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $8.26 | +130.02% | 3 | May 9, 2023 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $37 → $31 | $12.36 | +150.81% | 2 | Feb 14, 2023 | |
| CMPX Compass Therapeutics | Initiates: Buy | $9 | $1.45 | +520.69% | 1 | Jan 27, 2023 | |
| OABI OmniAb | Initiates: Buy | $12 | $4.48 | +167.86% | 1 | Nov 28, 2022 | |
| BOLT Bolt Biotherapeutics | Initiates: Buy | n/a | $1.11 | - | 1 | Mar 2, 2021 | |
| GERN Geron | Initiates: Buy | n/a | $3.79 | - | 1 | Aug 3, 2020 | |
| INO Inovio Pharmaceuticals | Downgrades: Hold | $228 → $288 | $10.57 | +2,624.69% | 4 | Jun 26, 2020 | |
| MTEM Molecular Templates | Initiates: Buy | n/a | $1.71 | - | 1 | Mar 25, 2020 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | n/a | $143.31 | - | 3 | Aug 13, 2018 | |
| IONS Ionis Pharmaceuticals | Maintains: Hold | n/a | $41.59 | - | 2 | Aug 8, 2018 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | n/a | $80.91 | - | 3 | Aug 3, 2018 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | n/a | $1.58 | - | 2 | Jul 31, 2018 | |
| INVA Innoviva | Terminates: Hold | n/a | $15.26 | - | 2 | Jun 25, 2018 | |
| GLYC GlycoMimetics | Maintains: Buy | n/a | $1.64 | - | 1 | Mar 7, 2018 | |
| ARRY Array Technologies | Maintains: Buy | n/a | $12.40 | - | 1 | Feb 7, 2018 | |
| SPRO Spero Therapeutics | Initiates: Buy | n/a | $1.46 | - | 1 | Nov 27, 2017 |
MEI Pharma
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $3.05
Upside: +129.51%
Cue Biopharma
Apr 9, 2024
Maintains: Buy
Price Target: $8
Current: $1.37
Upside: +486.08%
Vor Biopharma
Mar 21, 2024
Maintains: Buy
Price Target: $15 → $12
Current: $1.69
Upside: +610.06%
Incyte
Mar 12, 2024
Reiterates: Hold
Price Target: $68
Current: $51.68
Upside: +31.58%
MacroGenics
Mar 8, 2024
Maintains: Buy
Price Target: $17 → $29
Current: $14.56
Upside: +99.18%
AbCellera Biologics
Feb 21, 2024
Maintains: Buy
Price Target: $21 → $17
Current: $3.76
Upside: +352.13%
Exelixis
Feb 2, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $23.70
Upside: +5.49%
Compugen
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.92
Upside: +108.33%
Xenon Pharmaceuticals
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $40.50
Upside: +53.09%
IGM Biosciences
Nov 14, 2023
Maintains: Buy
Price Target: $26 → $25
Current: $9.40
Upside: +165.96%
HilleVax
Nov 10, 2023
Maintains: Buy
Price Target: $35 → $30
Current: $12.79
Upside: +134.56%
Atreca
Aug 11, 2023
Downgrades: Hold
Price Target: $4 → $1
Current: $0.08
Upside: +1,150.00%
X4 Pharmaceuticals
May 17, 2023
Maintains: Buy
Price Target: $4 → $5
Current: $1.17
Upside: +329.18%
Nkarta
May 12, 2023
Maintains: Buy
Price Target: $21 → $18
Current: $6.87
Upside: +162.01%
Zymeworks
May 9, 2023
Maintains: Buy
Price Target: $18 → $19
Current: $8.26
Upside: +130.02%
Nurix Therapeutics
Feb 14, 2023
Maintains: Buy
Price Target: $37 → $31
Current: $12.36
Upside: +150.81%
Compass Therapeutics
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $1.45
Upside: +520.69%
OmniAb
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $4.48
Upside: +167.86%
Bolt Biotherapeutics
Mar 2, 2021
Initiates: Buy
Price Target: n/a
Current: $1.11
Upside: -
Geron
Aug 3, 2020
Initiates: Buy
Price Target: n/a
Current: $3.79
Upside: -
Inovio Pharmaceuticals
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $10.57
Upside: +2,624.69%
Molecular Templates
Mar 25, 2020
Initiates: Buy
Price Target: n/a
Current: $1.71
Upside: -
Alnylam Pharmaceuticals
Aug 13, 2018
Maintains: Buy
Price Target: n/a
Current: $143.31
Upside: -
Ionis Pharmaceuticals
Aug 8, 2018
Maintains: Hold
Price Target: n/a
Current: $41.59
Upside: -
BioMarin Pharmaceutical
Aug 3, 2018
Maintains: Buy
Price Target: n/a
Current: $80.91
Upside: -
Lexicon Pharmaceuticals
Jul 31, 2018
Maintains: Buy
Price Target: n/a
Current: $1.58
Upside: -
Innoviva
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $15.26
Upside: -
GlycoMimetics
Mar 7, 2018
Maintains: Buy
Price Target: n/a
Current: $1.64
Upside: -
Array Technologies
Feb 7, 2018
Maintains: Buy
Price Target: n/a
Current: $12.40
Upside: -
Spero Therapeutics
Nov 27, 2017
Initiates: Buy
Price Target: n/a
Current: $1.46
Upside: -